A total of 283 eligible patients with pT3-4a and/or node-positive disease were randomly assigned after radical nephrectomy and lymphadenectomy to observation or to interferon alfa-NL ( Wellferon , Burroughs-Wellcome , Research Park , NC ) given daily for 5 days every 3 weeks for up to 12 cycles .
